Repository logo
 
Publication

Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy

dc.contributor.authorBoyd, Patricia Anne
dc.contributor.authorLoane, Maria
dc.contributor.authorGarne, Ester
dc.contributor.authorKhoshnood, Babak
dc.contributor.authorDolk, Helen
dc.contributor.authorEUROCAT working group
dc.date.accessioned2012-02-15T16:12:05Z
dc.date.available2012-02-15T16:12:05Z
dc.date.issued2011-08-25
dc.descriptionEUROCAT Working group collaborator: Carlos Diaspor
dc.description.abstractThis study aims to assess prevalence and pregnancy outcome for sex chromosome trisomies (SCTs) diagnosed prenatally or in the first year of life. Data held by the European Surveillance of Congenital Anomalies (EUROCAT) database on SCT cases delivered 2000–2005 from 19 population-based registries in 11 European countries covering 2.5 million births were analysed. Cases included were livebirths diagnosed to 1 year of age, fetal deaths from 20 weeks gestation and terminations of pregnancy for fetal anomaly (TOPFA). In all, 465 cases of SCT were diagnosed between 2000 and 2005, a prevalence of 1.88 per 10,000 births (95% CI 1.71–2.06). Prevalence of XXX, XXY and XYY were 0.54 (95% CI 0.46–0.64), 1.04 (95% CI 0.92–1.17) and 0.30 (95% CI 0.24–0.38), respectively. In all, 415 (89%) were prenatally diagnosed and 151 (36%) of these resulted in TOPFA. There was wide country variation in prevalence (0.19–5.36 per 1000), proportion prenatally diagnosed (50–100%) and proportion of prenatally diagnosed resulting in TOPFA (13–67%). Prevalence of prenatally diagnosed cases was higher in countries with high prenatal detection rates of Down syndrome. The EUROCAT prevalence rate for SCTs diagnosed prenatally or up to 1 year of age represents 12% of the prevalence expected from cytogenetic studies of newborn babies, as the majority of cases are never diagnosed or are diagnosed later in life. There is a wide variation between European countries in prevalence, prenatal detection and TOPFA proportions, related to differences in screening policies as well as organizational and cultural factors.por
dc.identifier.citationEur J Hum Genet. 2011 Feb;19(2):231-4. Epub 2010 Aug 25por
dc.identifier.issn1018-4813
dc.identifier.otherdoi:10.1038/ejhg.2010.148
dc.identifier.urihttp://hdl.handle.net/10400.18/567
dc.language.isoengpor
dc.peerreviewedyespor
dc.publisherNature Publishing Grouppor
dc.relation.publisherversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025783/?tool=pubmedpor
dc.subjectSex Chromosome Trisomiespor
dc.subjectPrenatal Diagnosispor
dc.subjectTermination of Pregnancypor
dc.subjectEstados de Saúde e de Doençapor
dc.subjectRENACpor
dc.titleSex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancypor
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage234por
oaire.citation.startPage231por
oaire.citation.titleEuropean Journal of Human Geneticspor
rcaap.rightsopenAccesspor
rcaap.typearticlepor

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Sex Chromosome Trisomies in Europe - Prevalence, Prenatal Detection and outcome of Pregnancy.pdf
Size:
302.42 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: